Renaissance Technologies 13F Holdings & Portfolio

Managed by Jim Simons. Every U.S. equity position disclosed in Renaissance Technologies's Q1 2026 SEC Form 13F filing, with portfolio weights, share counts, and position values.

Jim Simons Q1 2026 Updated Jun 30, 2026
Mirror Renaissance Technologies In your own broker · Never custodial
Portfolio value (13F)
$63.9B
Disclosed positions
3213
Est. 1Y return
+26.1%
Est. YTD return
+48.6%
Latest filing
Q1 2026

Renaissance Technologies portfolio holdings (Q1 2026)

Long U.S. equity positions from the latest 13F filing, ranked by portfolio weight. "Recent change" reflects the quarter-over-quarter direction of each position.

TickerCompanyWeightSharesValueRecent change
91307C102 United Therapeutics Corp Del 1.7% 1.79M $1.1B Reduced 6.4%
PLTR Palantir Technologies Inc 1.6% 6.99M $1.0B Reduced 20.58%
AAPL Apple Inc 1.2% 3.08M $781M New Position
496902404 Kinross Gold Corp 1.2% 25.55M $780M Added 2.29%
MU Micron Technology Inc 1.1% 2.16M $731M Reduced 28.17%
VRSN Verisign Inc 1.1% 2.82M $700M Added 1.4%
30161Q104 Exelixis Inc 0.9% 13.73M $589M Reduced 1.34%
351858105 Franco Nev Corp 0.9% 2.22M $548M Reduced 10.46%
80004C200 Sandisk Corp 0.8% 799.6K $508M Reduced 33.87%
NVDA Nvidia Corporation 0.7% 2.53M $441M Added 189.98%
CVX Chevron Corporation 0.7% 2.02M $417M Reduced 8.03%
771049103 Roblox Corp 0.6% 7.13M $403M Added 7.51%
146869102 Carvana Co 0.6% 1.20M $378M Reduced 14.65%
94419L101 Wayfair Inc 0.6% 4.97M $374M Reduced 8.04%
770700102 Robinhood Mkts Inc 0.6% 5.10M $354M Added 48.56%
45337C102 Incyte Corp 0.5% 3.65M $344M Reduced 8.21%
04010E109 Argan Inc 0.5% 610.9K $333M Added 2.05%
INTC Intel Corp 0.5% 7.40M $327M Reduced 25.18%
64125C109 Neurocrine Biosciences Inc 0.5% 2.42M $319M Added 8.04%
UNH Unitedhealth Group Inc 0.5% 1.16M $313M Added 45.39%
859241101 Sterling Infrastructure Inc 0.5% 766.9K $312M Reduced 4.52%
G54950103 Linde Plc 0.5% 629.8K $312M Added 394.75%
958102105 Western Digital Corp 0.5% 1.15M $310M Added 15.48%
12503M108 Cboe Global Mkts Inc 0.5% 1.10M $309M Reduced 3.41%
375558103 Gilead Sciences Inc 0.5% 2.15M $300M Reduced 22.81%
29786A106 Etsy Inc 0.5% 5.96M $298M Added 11.08%
01973R101 Allison Transmission Hldgs I 0.4% 2.26M $265M Reduced 13.03%
AVGO Broadcom Inc 0.4% 793.8K $246M Added 89191%
92537N108 Vertiv Holdings Co 0.4% 968.0K $243M Reduced 15.41%
58506Q109 Medpace Hldgs Inc 0.4% 504.7K $242M Added 8.32%

Frequently asked questions

What stocks does Renaissance Technologies hold?

In its Q1 2026 13F filing, Renaissance Technologies disclosed 3213 U.S. equity positions worth about $63.9B. Its largest positions include 91307C102, PLTR, AAPL, 496902404, MU. The full holdings table above shows each position's portfolio weight, share count, market value, and the most recent quarter-over-quarter change.

Who manages Renaissance Technologies?

Renaissance Technologies is run by Jim Simons. The positions shown here are reconstructed from the fund's official SEC Form 13F-HR filing, the same public record every institutional manager over $100M must submit each quarter.

What is Renaissance Technologies's biggest position?

Renaissance Technologies's largest disclosed holding is 91307C102 (United Therapeutics Corp Del) at about 1.7% of the 13F portfolio, a position worth roughly $1.1B.

Can I copy Renaissance Technologies's portfolio in my own account?

Yes. Tengu's marketplace includes institutional-tracking strategies that surface Renaissance Technologies's disclosed positions in your own account at supported brokerages when a new 13F is filed. Your money stays at your broker, Tengu routes only the trades you approve and never takes custody, and you can disconnect at any time. Note that 13F filings lag the actual trades by up to 45 days.

More tracked funds